Answers are grounded in this paper and cite their sources.
Following enactment of the Agriculture Improvement Act of 2018 (Farm Bill), there has been a rapid increase in interest and availability of ingestible cannabinoid hemp products (CHPs) in the United States (U.S) marketplace. Although cannabidiol (CBD) and THC (tetrahydrocannabinol) content were originally the focus of analysis of CHPs, products containing minor cannabinoid compounds, such as Δ8-tetrahydrocannabinol (Δ8-THC) or synthetic derivatives like Δ10-tetrahydrocannabinol (Δ10-THC), began to proliferate. To better characterise product composition in the evolving U.S. marketplace, effective methods for sampling and testing are warranted. However, due to the diversity of products, varying matrix interferences, and a broad range of cannabinoid concentrations, accurate quantification of their cannabinoid content is difficult. In this work, a method pairing QuEChERS extraction with UHPLC-MS/MS analysis to quantify 17 cannabinoids was developed and evaluated for several common CHP matrices, including gummy, oil, chocolate, chia seed powder, and coffee. The limits of quantification (LOQ) for all analytes were below 1 µg/g, and average recoveries for most analytes ranged from 70-130%. This method provides a valuable tool for researchers and testing laboratories analysing natural and synthetic cannabinoids in ingestible CHPs.
No takes yet. Share an insight, caveat, or question.
Pawar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: